Cargando…
The anti-tumoral potential of the saporin-based uPAR-targeting chimera ATF-SAP
The development of personalized therapies represents an urgent need owing to the high rate of cancer recurrence and systemic toxicity of conventional drugs. So far, targeted toxins have shown promising results as potential therapeutic compounds. Specifically, toxins conjugated to antibodies or fused...
Autores principales: | Zuppone, S., Assalini, C., Minici, C., Bertagnoli, S., Branduardi, P., Degano, M., Fabbrini, M. S., Montorsi, F., Salonia, A., Vago, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018701/ https://www.ncbi.nlm.nih.gov/pubmed/32054892 http://dx.doi.org/10.1038/s41598-020-59313-8 |
Ejemplares similares
-
Optimization of construct design and fermentation strategy for the production of bioactive ATF-SAP, a saporin based anti-tumoral uPAR-targeted chimera
por: Errico Provenzano, Alfredo, et al.
Publicado: (2016) -
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer
por: Zuppone, Stefania, et al.
Publicado: (2022) -
Integrin is on uPAR to unleash cells
por: LeBrasseur, Nicole
Publicado: (2003) -
uPAR's signaling two step
por: Leslie, Mitch
Publicado: (2007) -
Data on the regulation of moesin and merlin by the urokinase receptor (uPAR): Model explaining distal activation of integrins by uPAR
por: Degryse, Bernard, et al.
Publicado: (2017)